Cargando…

Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation

BACKGROUND: Respiratory viruses, including respiratory syncytial virus (RSV), can cause asthma exacerbations and bronchiolitis. Both conditions are associated with enhanced cognate immune responses and inflammation and reduced immune regulation. Lung epithelial cells (LECs) can contribute to antivir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, H, Su, Z, Schwarze, J
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2009
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655656/ https://www.ncbi.nlm.nih.gov/pubmed/18710906 http://dx.doi.org/10.1136/thx.2007.094870

Ejemplares similares

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data
por: Hedberg, Pontus, et al.
Publicado: (2022)

Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy
por: Spann, Kirsten M, et al.
Publicado: (2014)

Bacterial biofilms predominate in both acute and chronic human lung infections
por: Kolpen, Mette, et al.
Publicado: (2022)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infection
por: Fairchild, Robert M, et al.
Publicado: (2021)

Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection
por: Du, Yue, et al.
Publicado: (2022)

Bronchoalveolar CD4(+) T cell responses to respiratory antigens are impaired in HIV-infected adults
por: Jambo, Kondwani C, et al.
Publicado: (2011)

Face mask sampling reveals antimicrobial resistance genes in exhaled aerosols from patients with chronic obstructive pulmonary disease and healthy volunteers
por: Kennedy, Matthew, et al.
Publicado: (2018)

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells
por: Yamada, Souichi, et al.
Publicado: (2021)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection
por: Pearson, Hayley, et al.
Publicado: (2021)

Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
por: Hérivaux, Anaïs, et al.
Publicado: (2022)

Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study
por: Meghji, Jamilah, et al.
Publicado: (2020)

Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
por: Ao, Zhi, et al.
Publicado: (2023)

Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia
por: Hatchwell, Luke, et al.
Publicado: (2015)

Multicentre pilot study evaluation of lung ultrasound for the management of paediatric pneumonia in low-resource settings: a study protocol
por: Lenahan, Jennifer L, et al.
Publicado: (2018)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey
por: Wagner, Dirk, et al.
Publicado: (2020)

Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2020)

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
por: Fujita, Kohei, et al.
Publicado: (2014)

Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience
por: Mahmood, Kamran, et al.
Publicado: (2021)

Perceptions of medical students towards antibiotic prescribing for upper respiratory tract infections in Saudi Arabia
por: Harakeh, Steve, et al.
Publicado: (2015)

Neutrophils drive alveolar macrophage IL-1β release during respiratory viral infection
por: Peiró, Teresa, et al.
Publicado: (2018)

Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI)
por: Cooke, Jonathan, et al.
Publicado: (2015)

Pneumonia in newly diagnosed patients infected with the Omicron variant: a population-based study of Chinese patients in Chongqing
por: Wang, Huyu, et al.
Publicado: (2023)

A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro
por: Tang, Francesca S M, et al.
Publicado: (2016)

Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area
por: Sapey, Elizabeth, et al.
Publicado: (2020)

Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
por: Lauder, Sarah N, et al.
Publicado: (2011)

Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007–2010)
por: Zlateva, Kalina T, et al.
Publicado: (2020)

Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
por: Zhou, Guiling, et al.
Publicado: (2023)

Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol
por: Nakagawa, Taku, et al.
Publicado: (2019)

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
por: Shields, Adrian M, et al.
Publicado: (2021)

Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome
por: Wang, Li-Tzu, et al.
Publicado: (2023)

Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshire and Bristol, UK
por: Fyles, Fred, et al.
Publicado: (2023)

Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol
por: Binks, Michael J, et al.
Publicado: (2023)

Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI
por: Cooke, Jonathan, et al.
Publicado: (2020)

Effect of vitamin D(3) on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial
por: Vargas Buonfiglio, Luis G, et al.
Publicado: (2017)

Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response
por: Bergeron, Harrison C., et al.
Publicado: (2023)

How does rhinovirus cause the common cold cough?
por: Atkinson, Samantha K, et al.
Publicado: (2016)

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
por: Ewig, S, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1756r8kfsjdl89rbq7atf6abke